Skip to content

Paola Orozco, MD

NPI 1851136527ActiveIndividual· Internal Medicine· Columbia, MO

Internal Medicine (MD) in Columbia, Missouri, licensed in MO, with an NPI issued in June 2024. Part D covered 13 prescriptions written in 2024. Novo Nordisk Inc was the largest of 2 companies reporting payments in 2025, $141.72 in all, mostly food and beverage.

Overview

NPI1851136527
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJun 26, 2024
Last updated in NPPESMay 11, 2026
Certified by providerMay 11, 2026

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000X2024024861MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Pediatric Medicine (MO)

Part D prescriptions in 2024

Prescriptions (claims)13 · 21 30-day fills
Total drug cost$853.47

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$141.72 · 2 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$123.091
Alnylam Pharmaceuticals Inc.$18.631

What the 2025 payments were for

  • Food and Beverage$141.72 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Columbia

All 221 internal medicine physicians in Columbia · All internal medicine physicians in Missouri